Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Deferred Taxes (2018 - 2022)

Exelixis (EXEL) posted quarterly Deferred Taxes of $60.4 million for Q4 2022, up 526.14% year-over-year from $9.6 million in Q4 2021, and up 294.03% quarter-over-quarter from $15.3 million in Q3 2022.

Analysis

Exelixis (EXEL) Deferred Taxes (2018 - 2022) Analysis & Trends

Exelixis' Deferred Taxes history runs 5 years deep, the most recent figure standing at $60.4 million for Q4 2022.

  • In Q4 2022, Deferred Taxes rose 526.14% year-over-year to $60.4 million; the TTM figure through Mar 2023 stood at $75.7 million (up 216.01% YoY), while the FY2026 annual figure was -$126.2 million, down 312.31% from the prior year.
  • Deferred Taxes for Q4 2022 stood at $60.4 million, up from $15.3 million in the prior quarter.
  • The five-year high for Deferred Taxes was $244.1 million in Q4 2018, with the low at -$71.6 million in Q1 2021.
  • The 5-year median for Deferred Taxes is -$3.1 million (2021), against an average of $19.4 million.
  • Peak annual rise in Deferred Taxes reached 526.14% in 2022, while the deepest fall reached 552.13% in 2022.
  • Exelixis' Deferred Taxes stood at $244.1 million in 2018, then tumbled by 90.47% to $23.3 million in 2019, then slumped by 143.52% to -$10.1 million in 2020, then sank by 39.85% to -$14.2 million in 2021, then soared by 526.14% to $60.4 million in 2022.
  • Business Quant data shows EXEL's Deferred Taxes at $60.4 million in Q4 2022, $15.3 million in Q3 2022, and -$15.3 million in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.66 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 30, 2022 60.36 Mn
Jul 1, 2022 15.32 Mn
Apr 1, 2022 -15.32 Mn
Dec 31, 2021 -14.16 Mn
Oct 1, 2021 -9.57 Mn
Jul 2, 2021 -26.19 Mn
Apr 2, 2021 3.39 Mn
Jan 1, 2021 -71.60 Mn
Apr 3, 2020 -10.13 Mn
Sep 27, 2019 23.27 Mn
Jun 28, 2019 33.07 Mn
Dec 28, 2018 244.11 Mn